PL3242882T3 - Peptydy antagonistyczne wobec CGRP - Google Patents

Peptydy antagonistyczne wobec CGRP

Info

Publication number
PL3242882T3
PL3242882T3 PL16700059.5T PL16700059T PL3242882T3 PL 3242882 T3 PL3242882 T3 PL 3242882T3 PL 16700059 T PL16700059 T PL 16700059T PL 3242882 T3 PL3242882 T3 PL 3242882T3
Authority
PL
Poland
Prior art keywords
cgrp antagonist
antagonist peptides
peptides
cgrp
antagonist
Prior art date
Application number
PL16700059.5T
Other languages
English (en)
Inventor
Kazimierz Wisniewski
Guangcheng Jiang
Aleksandr K RABINOVICH
Javier J SUEIRAS-DIAZ
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of PL3242882T3 publication Critical patent/PL3242882T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
PL16700059.5T 2015-01-06 2016-01-06 Peptydy antagonistyczne wobec CGRP PL3242882T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562100371P 2015-01-06 2015-01-06
PCT/EP2016/050110 WO2016110499A1 (en) 2015-01-06 2016-01-06 Cgrp antagonist peptides

Publications (1)

Publication Number Publication Date
PL3242882T3 true PL3242882T3 (pl) 2022-10-31

Family

ID=55071041

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16700059.5T PL3242882T3 (pl) 2015-01-06 2016-01-06 Peptydy antagonistyczne wobec CGRP

Country Status (33)

Country Link
US (1) US9969775B2 (pl)
EP (1) EP3242882B1 (pl)
JP (1) JP6929227B2 (pl)
KR (1) KR102713739B1 (pl)
CN (1) CN107207567B (pl)
AR (1) AR103499A1 (pl)
AU (1) AU2016206059B2 (pl)
BR (1) BR112017013413A2 (pl)
CL (1) CL2017001761A1 (pl)
CO (1) CO2017007940A2 (pl)
DK (1) DK3242882T3 (pl)
EA (1) EA032082B1 (pl)
ES (1) ES2924410T3 (pl)
HR (1) HRP20220941T1 (pl)
HU (1) HUE059379T2 (pl)
IL (1) IL252903B (pl)
JO (1) JO3669B1 (pl)
LT (1) LT3242882T (pl)
MA (1) MA41311B1 (pl)
MD (1) MD3242882T2 (pl)
MX (1) MX387920B (pl)
MY (1) MY196439A (pl)
PH (1) PH12017501214A1 (pl)
PL (1) PL3242882T3 (pl)
PT (1) PT3242882T (pl)
RS (1) RS63467B1 (pl)
SA (1) SA517381865B1 (pl)
SG (1) SG11201705306UA (pl)
SI (1) SI3242882T1 (pl)
TN (1) TN2017000248A1 (pl)
TW (1) TWI717331B (pl)
UA (1) UA121490C2 (pl)
WO (1) WO2016110499A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018362018A1 (en) * 2017-11-06 2020-06-25 Auckland Uniservices Limited Peptide conjugate CGRP receptor antagonists and methods of preparation and uses thereof
EP4647082A1 (en) 2024-05-08 2025-11-12 NUVIE BIO, Inc. Pharmaceutical composition comprising a cgrp receptor antagonist for the treatment of acute migraine
WO2025202938A1 (en) 2024-03-26 2025-10-02 Nuvie Bio, Inc. Pharmaceutical composition comprising a cgrp receptor antagonist for the treatment of acute migraine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268474B1 (en) * 1998-04-30 2001-07-31 Creighton University Peptide antagonists of CGRP-receptor superfamily and methods of use
TW200533398A (en) 2004-03-29 2005-10-16 Bristol Myers Squibb Co Novel therapeutic agents for the treatment of migraine
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
WO2006041830A2 (en) * 2004-10-07 2006-04-20 Merck & Co., Inc. Cgrp receptor antagonists
AU2006205830A1 (en) * 2005-01-17 2006-07-20 Jerini Ag C5a receptor antagonists
CA2599925A1 (en) * 2005-03-14 2006-09-21 Merck & Co., Inc. Cgrp receptor antagonists
US8168592B2 (en) * 2005-10-21 2012-05-01 Amgen Inc. CGRP peptide antagonists and conjugates
ES2433251T5 (es) * 2005-11-14 2020-03-13 Teva Pharmaceuticals Int Gmbh Anticuerpos antagonistas dirigidos contra un péptido relacionado con el gen de la calcitonina y procedimientos que utilizan los mismos
EP2027106A2 (en) * 2006-06-13 2009-02-25 Vertex Pharmaceuticals Incorporated Cgrp receptor antagonists
EP2807187B1 (en) 2012-01-26 2017-07-26 Christopher J. Soares Peptide antagonists of the calcitonin cgrp family of peptide hormones and their use

Also Published As

Publication number Publication date
ES2924410T3 (es) 2022-10-06
WO2016110499A1 (en) 2016-07-14
JO3669B1 (ar) 2020-08-27
US9969775B2 (en) 2018-05-15
MX387920B (es) 2025-03-19
PT3242882T (pt) 2022-08-09
SG11201705306UA (en) 2017-07-28
SI3242882T1 (sl) 2022-09-30
NZ732771A (en) 2024-07-05
KR102713739B1 (ko) 2024-10-04
MX2017008893A (es) 2017-10-25
EA032082B1 (ru) 2019-04-30
EP3242882A1 (en) 2017-11-15
TW201630929A (zh) 2016-09-01
MY196439A (en) 2023-04-11
TN2017000248A1 (en) 2018-10-19
DK3242882T3 (en) 2022-08-08
IL252903B (en) 2021-01-31
MA41311A (fr) 2017-11-14
HRP20220941T1 (hr) 2022-10-28
IL252903A0 (en) 2017-08-31
CN107207567A (zh) 2017-09-26
AU2016206059A1 (en) 2017-07-20
EP3242882B1 (en) 2022-05-04
AU2016206059B2 (en) 2019-07-25
HUE059379T2 (hu) 2022-11-28
CL2017001761A1 (es) 2018-01-26
CO2017007940A2 (es) 2017-10-31
UA121490C2 (uk) 2020-06-10
PH12017501214A1 (en) 2018-01-08
EA201791456A1 (ru) 2018-01-31
RS63467B1 (sr) 2022-08-31
KR20170102302A (ko) 2017-09-08
LT3242882T (lt) 2022-08-25
SA517381865B1 (ar) 2021-09-15
US20180002378A1 (en) 2018-01-04
CA2973041A1 (en) 2016-07-14
CN107207567B (zh) 2021-11-23
MA41311B1 (fr) 2022-10-31
AR103499A1 (es) 2017-05-17
MD3242882T2 (ro) 2022-10-31
JP6929227B2 (ja) 2021-09-01
JP2018505213A (ja) 2018-02-22
BR112017013413A2 (pt) 2018-01-09
TWI717331B (zh) 2021-02-01

Similar Documents

Publication Publication Date Title
IL258892B (en) Calcitonin gene-related peptide receptor antagonists
IL258893A (en) Cgrp receptor antagonists
ZA201800452B (en) Cgrp receptor antagonists
IL258894A (en) Cgrp receptor antagonists
GB201520539D0 (en) Peptides
GB201520543D0 (en) Peptides
GB201520546D0 (en) Peptides
GB201520536D0 (en) Peptides
GB201520545D0 (en) Peptides
GB201520544D0 (en) Peptides
IL252903A0 (en) cgrp antagonist peptides
GB201506316D0 (en) Novel peptide
GB201520541D0 (en) Peptides
GB201520542D0 (en) Peptides
GB201520557D0 (en) Peptides
GB201520548D0 (en) Peptides
GB201518700D0 (en) Peptides
ZA201704249B (en) Cgrp antagonist peptides
HK1239678A1 (en) Cgrp antagonist peptides
ZA201807767B (en) Angiotensin-1-receptor antagonists
PT3464324T (pt) Antagonistas de recetores da angiotensina-1
GB201520538D0 (en) Peptides
GB201520537D0 (en) Peptides
GB201520535D0 (en) Peptides
GB201520534D0 (en) Peptides